Poliovirus Receptor anticorps (AA 21-343)

N° du produit ABIN7193491

Cet anticorps Souris Monoclonal détecte spécifiquement Poliovirus Receptor dans ELISA et FACS. Il présente une réactivité envers Humain.

Aperçu rapide pour Poliovirus Receptor anticorps (AA 21-343) (ABIN7193491)

Antigène: Poliovirus Receptor (PVR)

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Poliovirus Receptor est non-conjugé

Application: ELISA, Flow Cytometry (FACS)

Clone: 6D2D6

Détail du produit anti-Poliovirus Receptor anticorps

Épitope: AA 21-343

Fonction: CD155 Antibody

Purification: Purified antibody

Immunogène: Purified recombinant fragment of human CD155 (AA: 21-343) expressed in E. Coli.

Isotype: IgG1

Information d'application

Indications d'application:

ELISA: 1/10000

FCM: 1/200 - 1/400

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified antibody in PBS with 0.05 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Détails sur Poliovirus Receptor

Antigène: Poliovirus Receptor (PVR)

Autre désignation: CD155

Sujet:

The protein encoded by this gene is a transmembrane glycoprotein belonging to the immunoglobulin superfamily. The external domain mediates cell attachment to the extracellular matrix molecule vitronectin, while its intracellular domain interacts with the dynein light chain Tctex-1/DYNLT1. The gene is specific to the primate lineage, and serves as a cellular receptor for poliovirus in the first step of poliovirus replication. Multiple transcript variants encoding different isoforms have been found for this gene.

Poids moléculaire: 45.3 kDa

ID gène: 5817

UniProt: P15151

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interactome